ABSTRACT
Every chapter has been formatted in an effort to maximize use of the data tabulated. A brief narrative introducing the class of compounds is first presented in order to present an overview of the compounds presented. For frequently used therapeutic drugs, these introductions may be more exten sive. A list of selected readings is provided for more in-depth discussions of these compounds. Chemical structures are then presented for all compounds for which pharmacokinetic data is available. It must be stressed that the tabulation of the pharmacokinetic data in Table 4 of each section is the central reason for compiling this handbook. In order to maximize the use of these data, pertinent ancillary information is also tabulated when available. Every effort has been made to make these ancillary tables as complete as possible: however, data for all parameters for all drugs are not available.
